Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | 1 | G-CSF | 10.0 | 89 | |||||||
N2586 | 1 | G-CSF | 12.0 | 77 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | G-CSF | 12.0 | 50 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | G-CSF | 12.0 | 77 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | G-CSF | 12.0 | 67 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | G-CSF | 9.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | G-CSF | 10.0 | 63 | ||||
N2586 | 1 | G-CSF | 13.0 | 63 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 1 | G-CSF | 12.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 13.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 12.0 | 63 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 9.0 | 77 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 10.0 | 45 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 9.0 | 61 | |
N2586 | Visfatin | 1 | ng/mL | 1 | G-CSF | 10.5 | 66 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 11.0 | 58 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 11.0 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 7.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 11.0 | 51 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | G-CSF | 10.0 | 37 | |
0 | G-CSF | 12.0 | 56 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | G-CSF | 19.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | G-CSF | 17.5 | 42 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | G-CSF | 12.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | G-CSF | 16.0 | 37 |